List Results
Refine Search
Results by Topic
Results on Map
Search Details
Found 25 studies with search of: Open Studies | "Hemorrhagic Fevers, Viral"
Include studies that are not seeking new volunteers.
Hide studies with unknown recruitment status.
  Display Options
Rank Status Study
1 Not yet recruiting Study to Evaluate the Safety, Tolerability, and Immunogenicity of Hantaan and Puumala Virus DNA Vaccines
Condition: Hemorrhagic Fever With Renal Syndrome
Intervention: Biological: Vaccine/device combination for prevention of HFRS
2 Recruiting Study of a Novel Tetravalent Dengue Vaccine in Healthy Children and Adolescents Aged 9 to 16 Years in Latin America
Conditions: Dengue Fever;   Dengue Hemorrhagic Fever;   Dengue
Interventions: Biological: Live, attenuated, dengue serotype 1, 2, 3, 4 virus;   Biological: Placebo: NaCl 0.9% solution
3 Recruiting Study of a Booster Injection of Pentaxim™ Vaccine Administered With Dengue Vaccine in Healthy Toddlers
Conditions: Dengue;   Dengue Hemorrhagic Fever
Interventions: Biological: Live, attenuated, recombinant dengue serotype 1, 2, 3, and 4 virus;   Biological: DTaP IPV//Hib vaccine;   Biological: Placebo;   Biological: Measles, mumps, and rubella vaccine;   Biological: Pneumococcal vaccine
4 Recruiting Prospective Dengue Seroprevalence Study in 5 to 10 Year-old Children
Conditions: Dengue;   Dengue Fever;   Dengue Hemorrhagic Fever
Intervention:
5 Recruiting Study of a Novel Tetravalent Dengue Vaccine in Healthy Children Aged 2 to 14 Years in Asia
Conditions: Dengue;   Dengue Fever;   Dengue Hemorrhagic Fever
Interventions: Biological: Live, attenuated, dengue serotype 1, 2, 3, 4 virus;   Biological: Placebo: NaCl 0.9%
6 Recruiting Immune Response to Different Schedules of a Tetravalent Dengue Vaccine Given With or Without Yellow Fever Vaccine
Conditions: Dengue;   Dengue Fever;   Dengue Hemorrhagic Fever;   Yellow Fever
Interventions: Biological: Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus;   Biological: Yellow Fever + Live, attenuated, recombinant dengue serotypes 1, 2, 3, and 4 virus;   Biological: Yellow Fever
7 Recruiting Study of Yellow Fever Vaccine Administered With Tetravalent Dengue Vaccine in Healthy Toddlers
Conditions: Dengue;   Dengue Hemorrhagic Fever;   Yellow Fever
Interventions: Biological: Live, attenuated dengue serotype 1, 2, 3, and 4 virus;   Biological: Yellow fever vaccine;   Biological: Measles, mumps, and rubella vaccine;   Biological: Pneumococcal Conjugated Vaccine;   Biological: Hepatitis A Pediatric Vaccine;   Biological: Diphtheria, tetanus, pertussis, polio, and Haemophilus influenzae vaccine;   Biological: Yellow Fever Vaccine;   Biological: Placebo (NaCl)
8 Recruiting Safety Study of Single Administration Post-exposure Prophylaxis Treatment for Marburg Virus
Condition: Marburg Hemorrhagic Fever
Interventions: Drug: AVI-6003;   Drug: Placebo
9 Recruiting Adult Dengue Platelet Study
Condition: Dengue Fever
Interventions: Procedure: Platelet transfusion;   Procedure: Supportive care
10 Recruiting Study of Febrile Illness for Dengue-Endemic Areas in Latin America
Conditions: Dengue Fever;   Fever
Intervention:
11 Recruiting Laboratory Diagnosis and Prognosis of Severe Dengue
Condition: Dengue Fever
Intervention:
12 Recruiting Safety Study of a Vaccine (DENV-1 PIV) to Prevent Dengue Disease
Condition: Dengue Fever
Interventions: Biological: DENV-1 PIV, 2.5 µg;   Biological: DENV-1 PIV, 5 µg
13 Recruiting Evaluation of the Safety and the Ability of a DNA Vaccine to Protect Against Dengue Disease
Conditions: Dengue Disease;   Dengue Fever
Interventions: Biological: Tetravalent Dengue Vaccine (TVDV);   Biological: Tetravalent Dengue Vaccine (TVDV) with Vaxfectin® (low-dose);   Biological: Tetravalent Dengue Vaccine TVDV with Vaxfectin® (High Dose)
14 Recruiting Investigation of the Immuno-regulation and Viral Hepatitis Among Patients With or After Dengue Fever Infection
Condition: Dengue Fever
Intervention: Genetic: CLEC5A
15 Recruiting Safety, Tolerability and Pharmacokinetic First in Human (FIH) Study of Intravenous (IV) TKM-100201 Infusion
Condition: Ebola Virus Infection
Interventions: Drug: TKM-100201;   Drug: Placebo
16 Recruiting Safety and Immunogenicity Study of Rift Valley Fever Vaccine, Inactivated
Condition: Rift Valley Fever
Intervention: Biological: Inactivated, Dried (TSI-GSD 200), RVF Vaccine
17 Recruiting Evaluating the Safety and Immune Response to Two Admixtures of a Tetravalent Dengue Virus Vaccine
Condition: Dengue
Interventions: Biological: TetraVax-DV Vaccine - Admixture TV003;   Biological: TetraVax-DV Vaccine - Admixture TV005;   Biological: Placebo
18 Recruiting West Indies-French Guiana Dengue Study
Conditions: Fever;   Dengue
Interventions: Other: biological sample collection;   Other: quality of life questionnaire EuroQol®
19 Unknown † Prospective Study of Infant Dengue
Condition: Dengue
Intervention:
20 Recruiting Study to Evaluate the Incidence, Clinical Characteristics and Economic Burden of Dengue in Brazilian Children
Condition: Dengue Virus Infection
Interventions: Other: Data collection;   Procedure: Blood sample collection

Previous Page Studies Shown (1-20) Next Page (21-25)
† Indicates status has not been verified in more than two years
Save this search by bookmarking this page.
When you use your bookmark, the search will be performed again on the most recent collection of studies.
RSS Feeds for studies found by your search that were:
  First received in the last 14 days,  
  Last updated (includes received) in the last 30 days
  Download Options




Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services